Evercore ISI on Vaxcyte (PCVX): 'vaccine shakeup, but there's no change to PCV recs...'
Tweet Send to a Friend
Evercore ISI analyst Umer Raffat reiterated an Outperform rating and {REMOVEPT} price target on Vaxcyte (NASDAQ: PCVX).The analyst comments "Childhood ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
